The First Affiliated Hospital of Nanjing Medical University — Nanjing, Jiangsu

Public research footprint of The First Affiliated Hospital of Nanjing Medical University, compiled from the ClinicalTrials.gov public registry.

314

Registered studies

143

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Advanced Non-small Cell Lung Cancer, HER2 Mutation · Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic… · Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

Recently updated registry entries

NCT07609823 — A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL (Recruiting)
NCT03729453 — Intra-operative Pancreatoscopy in Patients With IPMN (Active Not Recruiting)
NCT07615348 — CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Affiliated Hospital of Nanjing Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.